Argonaut Manufacturing Services
Argonaut Manufacturing Services is a Carlsbad, CA-based contract development and manufacturing organization (CDMO) offering aseptic fill-finish, lyophilization, IVD, and drug-device combination product manufacturing services to biopharmaceutical, molecular diagnostics, and life sciences clients.
- Company typePrivate
- Founded2016
- HeadquartersCarlsbad, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Argonaut Manufacturing Services does
Argonaut Manufacturing Services is a Carlsbad, California-based contract development and manufacturing organization (CDMO) founded in 2016 that provides aseptic fill-finish, lyophilization, in-vitro diagnostics (IVD) manufacturing, and drug-device combination product (DDCP) services to biopharmaceutical, molecular diagnostics, and life sciences customers. Core technical capabilities center on isolator-based aseptic filling of vials, syringes, and cartridges under cGMP, supported by proprietary lyophilization platforms including LyoDots (miniaturized reagent format) and LyoDose (lyophilized bead technology for 96/384-well plates), plus the BioFuse sample-prep device for point-of-care workflows. The company operates five facilities in Carlsbad, holds ISO 13485:2016, cGMP, 21 CFR 210/211/820, and California FDB certifications, and its founding leadership has collective experience navigating 40+ FDA pre-approval inspections.
The business model is professional services plus per-batch contract manufacturing under multi-year agreements, with quote-based pricing that varies by product type, batch size, regulatory pathway, and scope. Revenue is generated through project-based development, clinical supply batches, and commercial supply agreements, with go-to-market executed via direct enterprise field sales, strategic ecosystem partners (KBI Biopharma, Abzena, Avid Bioservices, Cytiva, Ensera), and event-driven demand generation. Named customers include Bluejay Diagnostics, the Broad Institute (Vallabh/Minikel Lab for siRNA prion-disease therapeutics), n-Lorem Foundation (ASO medicines for nano-rare diseases), and UC San Diego Health. As of 2023 the company employed 133 FTEs with stated plans to scale to 300 while tripling revenue over five years, funded by a $45 million equity round in March 2024 led by NewVale Capital with Telegraph Hill Partners.
Argonaut Manufacturing Services firmographics
Firmographics- Name
- Argonaut Manufacturing Services
- Legal name
- Argonaut Manufacturing Services, Incorporated
- Website
- https://argonautms.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Argonaut Manufacturing Services is a Carlsbad, CA-based contract development and manufacturing organization (CDMO) offering aseptic fill-finish, lyophilization, IVD, and drug-device combination product manufacturing services to biopharmaceutical, molecular diagnostics, and life sciences clients.
- Ownership category
- akta.pro rank
Argonaut Manufacturing Services industry classification
Industry- Product category
- Contract Pharmaceutical Manufacturing (CDMO)
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Drug Substance–Drug Product Integrated CDMO (HLAGABAG)
- akta.pro secondary industries
- Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH), Process Development & Tech Transfer Services (CDMO) (HLAGABAL)
Keywords
Where Argonaut Manufacturing Services is headquartered
LocationHeadquarters
- HQ city
- Carlsbad
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Argonaut Manufacturing Services business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Contract Manufacturing Services: Service-based contracts for aseptic fill-finish, lyophilization, IVD manufacturing, and drug-device combination products. Revenue generated through project fees, per-batch pricing, and per-unit manufacturing fees under long-term supply agreements.
- Per-Batch Manufacturing: Revenue from individual manufacturing batches for clinical and commercial supply, with pricing based on batch size, complexity, and regulatory requirements
- Project-Based Development Services: Revenue from process development, scale-up, and tech transfer services prior to commercial manufacturing
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom quote-based pricing tailored to specific manufacturing requirements |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
Argonaut Manufacturing Services product offering
Product offeringCore offering
Argonaut Manufacturing Services is a contract manufacturing organization (CMO/CDMO) providing aseptic fill-finish, lyophilization (freeze-drying), drug-device combination product assembly, and in-vitro diagnostics (IVD) and life sciences kit manufacturing for biopharmaceutical, diagnostics, and life science companies. Services include sterile liquid filling, non-sterile fill-finish, analytical and quality control testing, and GMP storage and logistics.
Product overview
Argonaut Manufacturing Services is a contract development and manufacturing organization (CDMO) offering a comprehensive suite of pharmaceutical and life sciences manufacturing services. The core offerings include aseptic fill-finish services for vials, syringes, and cartridges; drug-device combination products (DDCP); in-vitro diagnostics and life sciences kit manufacturing; and lyophilization services including proprietary LyoDots and LyoDose bead technology. Supporting services include analytical/quality control, GMP storage and logistics, and non-sterile fill-finish with terminal sterilization. The company operates from Carlsbad, CA with isolator-based filling lines compliant with Annex 1 and FDA standards.
Differentiator
Problem solved
Functional benefit
Brands
- LyoDots: World's smallest lyophilized reagents - miniaturized format for diagnostic and point-of-care devices, stable at room temperature, automation friendly
- BioFuse
- LyoDose
Products and services
- Aseptic Fill & Finish Services Sterile liquid filling of injectable drug products using isolator-based aseptic processing for biopharmaceutical clients requiring FDA-registered cGMP capacity.
- Lyophilization Services
- Drug-Device Combination Products
- In-Vitro Diagnostics (IVD) and Life Sciences Kits
- Non-Sterile Fill Finish
- BioFuse Sample Prep Device A proprietary sample preparation device developed by Argonaut for use in diagnostic and life science workflows.
- LyoDots A proprietary lyophilization technology platform developed by Argonaut for freeze-drying applications.
- Analytical & Quality Control Services
- GMP Storage & Logistics
Quantifiable outcome
- 100+ completed client programs delivered successfully
- +1 more outcomes
Companies that use Argonaut Manufacturing Services
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles3 records
Argonaut Manufacturing Services technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Argonaut Manufacturing Services partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, flagship and minor.
- Ensera TherapeuticscorePartnership for drug-device combination product manufacturing. Argonaut provides expertise in combining pharmaceutical compounds with medical device components for integrated therapeutic products.
- Bluejay DiagnosticscoreManufacturing partnership for Symphony platform diagnostic products. Argonaut provides IVD manufacturing capabilities for Bluejay's point-of-care diagnostic technology.
- Broad Institute (Vallabh/Minikel Lab)coreManufacturing partnership for siRNA therapeutic products targeting prion disease. Argonaut provides GMP manufacturing for clinical supply of novel RNA-based therapeutics.
- n-Lorem FoundationflagshipManufacturing partnership for ASO (antisense oligonucleotide) medicines for nano-rare diseases. Supports n-Lorem's mission to provide free, personalized ASO medicines to patients with nano-rare diseases caused by unique genetic mutations.
- AbzenacorePartnership for end-to-end drug development support from early discovery through commercial manufacturing. Abzena provides antibody and protein engineering capabilities combined with Argonaut's fill-finish expertise.
- KBI BiopharmaflagshipStrategic alliance for integrated drug substance and drug product manufacturing. KBI Biopharma provides drug substance development and manufacturing while Argonaut provides fill-finish and drug product manufacturing capabilities. Awarded Fill-Finish CDMO of the Year recognition in 2026.
- Avid BioservicescoreStrategic CDMO partnership for integrated biologics manufacturing from cell line development through fill-finish.
- BrainSporesminorStrategic partnership for brain delivery therapeutics and diagnostics manufacturing.
Scale indicators7 records
Recent moves9 records
Expansion highlights6 records
Argonaut Manufacturing Services competitors and assessment
Company assessmentDirect peers
- PCI Pharma Services: Global CDMO providing integrated drug development, manufacturing, and packaging services including drug-device combination products. PCI competes directly with Argonaut in combination product manufacturing and aseptic fill-finish, but at significantly greater scale and geographic breadth.
- KBI Biopharma: Biologics-focused CDMO offering drug substance development and manufacturing. KBI is Argonaut's flagship strategic partner and directly adjacent in the biopharma manufacturing value chain—KBI handles drug substance while Argonaut handles fill-finish, making them both collaborators and competitors for integrated contracts.
- Grand River Aseptic Manufacturing: Aseptic fill-finish CDMO offering sterile injectable manufacturing for clinical and commercial supply. GRAM is a similar-scale mid-sized competitor to Argonaut in the aseptic fill-finish market, targeting similar biopharma clients with overlapping service offerings.
- Vibalogics: CDMO specializing in fill-finish of viral vectors, vaccines, and live biologics. Vibalogics competes directly with Argonaut for aseptic fill-finish contracts in the biologics space, particularly for clinical and commercial supply of complex biopharmaceuticals.
- Abzena: Biopharma services organization offering antibody engineering, protein development, and manufacturing services. Abzena is Argonaut's Core strategic partner for end-to-end drug development, and competes for integrated biopharmaceutical development and manufacturing contracts.
- Avid Bioservices: CDMO specializing in biologics manufacturing from cell line development through fill-finish. Avid is both a strategic CDMO partner of Argonaut (per their partnership data) and a competitor for integrated biologics manufacturing engagements with biopharma clients.
Regional players
- Baccinex: Swiss-based CDMO specializing in sterile fill-finish of liquid and lyophilized vials for clinical and commercial supply. Baccinex competes with Argonaut in aseptic fill-finish but primarily serves European biopharma clients, providing a regional comparison point.
Broad incumbents
- Catalent: One of the largest global CDMOs offering comprehensive drug development, biologics manufacturing, and fill-finish services across dozens of facilities worldwide. Catalent is a broad incumbent competitor whose scale and breadth compete with Argonaut for large commercial contracts.
- Recipharm: European-headquartered CDMO providing contract development and manufacturing services including sterile fill-finish and biologics. Recipharm competes with Argonaut in the broader fill-finish CDMO market, particularly for European-sourced contracts.
Emerging players
- INCOG BioPharma Services: Emerging aseptic fill-finish CDMO offering sterile injectable manufacturing with recent capacity expansions. INCOG is a similar-stage emerging competitor to Argonaut, both having recently built or expanded capacity targeting mid-to-large biopharma clients.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Argonaut Manufacturing Services social profiles
Digital presenceArgonaut Manufacturing Services compliance and trust
Trust signalCompliance7 records
Argonaut Manufacturing Services financial estimates
Financial estimateRevenue estimate
Valuation estimate
Argonaut Manufacturing Services leadership team
Management profileNumber of profiles
Profiles12 records
Argonaut Manufacturing Services funding detail
Funding detailFunding overview
Funding rounds4 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Argonaut Manufacturing Services M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Argonaut Manufacturing Services
What does Argonaut Manufacturing Services do?
Argonaut Manufacturing Services is a contract manufacturing organization (CMO/CDMO) providing aseptic fill-finish, lyophilization (freeze-drying), drug-device combination product assembly, and in-vitro diagnostics (IVD) and life sciences kit manufacturing for biopharmaceutical, diagnostics, and life science companies. Services include sterile liquid filling, non-sterile fill-finish, analytical and quality control testing, and GMP storage and logistics.
Is Argonaut Manufacturing Services a public or private company?
Argonaut Manufacturing Services is a private company. It is classified as venture growth investor backed and is currently operating.
When was Argonaut Manufacturing Services founded?
Argonaut Manufacturing Services was founded in 2016. It employs 51 to 100 people.
Where is Argonaut Manufacturing Services based?
Argonaut Manufacturing Services is headquartered in Carlsbad, United States, in the North America region.
How does Argonaut Manufacturing Services make money?
Three revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are per-Batch Manufacturing and project-Based Development Services.
Who are Argonaut Manufacturing Services's main competitors?
Direct peers on record are PCI Pharma Services, KBI Biopharma, Grand River Aseptic Manufacturing, Vibalogics, Abzena and Avid Bioservices. Baccinex is listed as a regional player. Broad incumbents are Catalent and Recipharm. INCOG BioPharma Services is listed as an emerging player.
Does Argonaut Manufacturing Services have an API?
No public API is recorded for Argonaut Manufacturing Services.
What industry is Argonaut Manufacturing Services in?
Argonaut Manufacturing Services's product category is Contract Pharmaceutical Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAG, Drug Substance–Drug Product Integrated CDMO, with a secondary code of HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO. Its NAICS code is 32541 and its SIC code is 5047.